MSD is a global research-driven pharmaceutical company established in 1891, known as Merck in USA and Canada. Through discovering, developing, manufacturing and marketing vaccines, consumer health products, animal health products and medicines we are addressing unmet medical needs. We devote extensive efforts to increase access to medicines through far-reaching programs, policies and partnerships that not only donate MSD medicines but help deliver them to the people who need them.
MSD Norway was established in 1970 and holds today 115 employees at the Drammen office. MSD Norway is one of the biggest contributors to pharmaceutical clinical studies in Norway. Through our study programs we provide important knowledge about medicines’ efficacy and safety, facilitate that Norwegian clinicians get experience with new treatments and most importantly help ensure Norwegian patients get early access to innovative medicines.
Our focus on oncology
Our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer worldwide. At MSD Oncology, helping people fight cancer is our passion and supporting accessibility to our cancer medicines is our commitment. Our focus is on pursuing research in immuno-oncology and we are accelerating every step in the journey – from lab to clinic – to potentially bring new hope to people with cancer.